We are open with limited hours and staff.
Price range: $169.00 through $757.00
Hydrocodone 7.5/325mg is a prescription combination medicine containing 7.5mg of hydrocodone bitartrate and 325mg of acetaminophen in each tablet. Hydrocodone is an opioid analgesic, while acetaminophen is a non-opioid pain reliever. Together, these ingredients provide a combination approach to managing pain when an opioid medicine is considered medically appropriate.
Because hydrocodone is a potent opioid, its use requires careful medical supervision. In addition, the acetaminophen component creates important considerations for liver safety. Therefore, patients should rely on current prescribing information and guidance from a qualified healthcare professional.
Hydrocodone 7.5/325mg belongs to a class of prescription opioid pain medicines. Current labeling describes hydrocodone bitartrate and acetaminophen tablets as medicines for pain severe enough to require an opioid when alternative treatments do not provide adequate relief or cannot be tolerated.
The two active ingredients work differently. Hydrocodone acts primarily through opioid receptors in the central nervous system and changes how the body perceives pain. Meanwhile, acetaminophen provides additional analgesic and fever-reducing effects.
Healthcare professionals may prescribe this combination for appropriate pain-management situations. However, treatment decisions depend on the individual patient’s condition, previous analgesic exposure, medical history, and potential risks.
Furthermore, opioid treatment requires ongoing assessment because individual responses can vary. For that reason, information found online should not replace a personalized evaluation from a healthcare professional.
Hydrocodone carries serious risks, including addiction, abuse, misuse, overdose, and life-threatening respiratory depression. The risk can increase when opioids are taken with alcohol, benzodiazepines, or other central nervous system depressants.
Acetaminophen also requires careful attention. Excessive exposure can cause serious liver injury, particularly when someone combines multiple medicines containing acetaminophen. Consequently, patients should review all prescription and over-the-counter medicines with their healthcare professional or pharmacist.
Potential effects associated with hydrocodone-containing medicines include drowsiness, dizziness, nausea, vomiting, constipation, and reduced alertness. Because these effects can interfere with normal activities, patients should understand their individual response before driving or performing tasks that require concentration.
Moreover, certain respiratory, liver, kidney, or substance-use conditions may require additional medical assessment. Other medicines can also increase sedation or respiratory-depression risks, so a complete medication review is important.
Hydrocodone 7.5/325mg is identified in U.S. labeling as a Schedule II controlled substance and is available only by prescription.
Therefore, patients should follow the instructions provided by their prescribing professional. Medication should never be shared with another person, even when symptoms appear similar. It should also be stored securely and kept away from children and anyone who might use it accidentally or improperly.
If someone develops extreme sleepiness, unusually slow or difficult breathing, loss of consciousness, or other signs of opioid overdose, emergency medical assistance should be obtained immediately.
Hydrocodone 7.5/325mg combines 7.5mg of hydrocodone bitartrate with 325mg of acetaminophen in a prescription tablet. Current DailyMed records document this strength among hydrocodone-acetaminophen tablets.
In summary, the hydrocodone component makes responsible opioid prescribing essential, while the acetaminophen component requires attention to total acetaminophen exposure. For the safest approach, patients should use current official labeling and professional medical guidance rather than relying on online dosing information or historical product descriptions.
